Clinical Trial

Risk Factors for Hormonal Therapy Failure in Patients With Endometriosis.

Study acronym: ENDOFAIL-01
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 19, 2024 (before its estimated July 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The primary objective of our study is to determine the percentage of patients with endometriosis who are non-responsive to medical therapy after 12 months and to compare the clinical and ultrasound characteristics of this group of patients (study group) with the clinical and ultrasound characteristics of patients who are responsive to medical therapy (control group). The secondary objective of the study will be to determine the percentage of patients with endometriosis who are non-responsive to medical therapy after 6 months and to compare the clinical and ultrasound characteristics of this group of patients (study group) with the clinical and ultrasound characteristics of patients who are responsive to medical therapy (control group).
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06510647
Lead Sponsor University of Cagliari
Conditions Endometriosis
Enrollment 247 participants
Start Date 2024-02-26
Primary Completion 2025-07-01 (estimated)
Study Completion 2026-05-31 (estimated)
Updated on ClinicalTrials.gov 2024-07-19